Bright CD38 and Dim CD20 by Flow Cytometry May Predict for Double Hit Lymphomas in MYC Rearranged High-Grade B-Cell Lymphomas

被引：0
作者：
Willis, J. S. [1 ]
Seegmiller, A. C. [1 ]
Uddin, N. [1 ]
Karandikar, N. J. [1 ]
Chen, W. [1 ]
机构：
[1] UT SW Med Ctr, Dallas, TX USA
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1397
引用
收藏
页码：329A / 329A
页数：1
相关论文
共 50 条
  • [21] Characterization of p53 and CD99 Expression in MYC Rearranged, Increased MYC Copy Number and MYC Negative High Grade B-Cell Lymphomas
    Richardson, Aida
    Zhang, Da
    Woodroof, Janet
    Cui, Wei
    LABORATORY INVESTIGATION, 2018, 98 : 547 - 548
  • [22] THE DIAGNOSTIC CHALLENGE OF RITUXIMAB-INDUCED CD20 NEGATIVE B-CELL LYMPHOMAS
    Risser, J.
    Breen, C.
    Feder, S.
    O'Leary, E.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (01) : 159 - 159
  • [23] Flow cytometry is of limited utility in the early identification of "Double-hit" B-cell lymphomas
    Platt, Mia Y.
    DeLelys, Michelle E.
    Preffer, Frederic I.
    Sohani, Aliyah R.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84B (03) : 143 - 148
  • [24] Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)
    Habermann, Thomas M.
    Macon, William R.
    Maurer, Matthew J.
    Ketterling, Rhett P.
    Kurtin, Paul J.
    Feldman, Andrew L.
    Vaidya, Rakhee
    Cerhan, James R.
    Ansell, Stephen
    Porrata, Luis
    Nowakowski, Grzegorz S.
    Witzig, Thomas E.
    McPhail, Ellen D.
    BLOOD, 2016, 128 (22)
  • [25] "Double Hit" High-Grade B-Cell Lymphomas: An Aggressive Disease with Heterogeneous Histologic Features and Clinical Outcome
    Li, S.
    Medeiros, L. J.
    Fayad, L. E.
    Lennon, P. A.
    Yin, C. C.
    Lin, P.
    LABORATORY INVESTIGATION, 2011, 91 : 306A - 307A
  • [26] "Double Hit" High-Grade B-Cell Lymphomas: An Aggressive Disease with Heterogeneous Histologic Features and Clinical Outcome
    Li, S.
    Medeiros, L. J.
    Fayad, L. E.
    Lennon, P. A.
    Yin, C. C.
    Lin, P.
    MODERN PATHOLOGY, 2011, 24 : 306A - 307A
  • [27] Immunophenotypic Differentiation of CD10 Positive B-Cell Lymphomas by Flow Cytometry
    McGowan, P. J.
    Wimmer, J.
    Nelles, N.
    Curry, C. V.
    Chang, C-C
    Zu, Y.
    Ewton, A.
    Sheehan, A.
    MODERN PATHOLOGY, 2011, 24 : 309A - 309A
  • [28] Immunophenotypic Differentiation of CD10 Positive B-Cell Lymphomas by Flow Cytometry
    McGowan, P. J.
    Wimmer, J.
    Nelles, N.
    Curry, C. V.
    Chang, C-C
    Zu, Y.
    Ewton, A.
    Sheehan, A.
    LABORATORY INVESTIGATION, 2011, 91 : 310A - 310A
  • [29] Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas
    Pagel, John M.
    Pantelias, Anastasia
    Hedin, Nathan
    Wilbur, Shani
    Saganic, Laura
    Lin, Yukang
    Axworthy, Donald
    Hamlin, Donald K.
    Wilbur, D. Scott
    Gopal, Ajay K.
    Press, Oliver W.
    CANCER RESEARCH, 2007, 67 (12) : 5921 - 5928
  • [30] Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas
    Schuster, Stephen J.
    Huw, Ling-Yuh
    Bolen, Christopher R.
    Maximov, Victor
    Polson, Andrew G.
    Hatzi, Katerina
    Lasater, Elisabeth A.
    Assouline, Sarit E.
    Bartlett, Nancy L.
    Budde, L. Elizabeth
    Matasar, Matthew J.
    Koeppen, Hartmut
    Piccione, Emily C.
    Wilson, Deanna
    Wei, Michael C.
    Yin, Shen
    Penuel, Elicia
    BLOOD, 2024, 143 (09) : 822 - 832
12345